

KKR vs CME Group
Global alternative asset manager with private equity and credit vs Global futures and options exchange operator providing clearing services. Which is the better buy for your portfolio in November 2026? Plain-English answer below.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest derivatives exchange and earns fees on every futures and options contract traded. Both firms benefit from financial market complexity and the growing institutional need to manage risk or access alternative returns. The KKR vs CME Group comparison contrasts performance-driven asset management economics with the near-utility-like fee stability of exchange infrastructure.
KKR is one of the world's premier alternative asset managers raising and deploying capital across private equity, credit, and real assets at global scale, while CME Group operates the world's largest ...
Why It’s Moving

KKR Closes Major Deals and Books $2B Net Income Boost as Analysts Eye Significant Upside
- KKR completed the sale of USI Insurance Services to Aon plc, generating approximately $3.3 billion in after-tax proceeds and an expected $2.0 billion in Adjusted Net Income for Q4 2026.
- The firm finalized its $5.7 billion acquisition of Integer Holdings Corporation, a leading medical device contract development and manufacturing organization, signaling continued expansion into healthcare infrastructure.
- KKR joined Carlyle in providing approximately $475 million in new capital commitments to Litmus Music, supporting the growth of its music royalty platform and diversifying alternative asset exposure.

CME Group Highlights Dominance in Derivatives and Prediction Markets Amid Analyst Downside Warnings
- CEO Terry Duffy discussed the integration of prediction markets alongside traditional financial instruments during a recent appearance on 'Power Lunch', highlighting new revenue avenues.
- Analysts note that CME maintains a dominant position in global derivatives with exceptionally high net margins, supported by a technology partnership with Alphabet.
- The company is cited for its wide economic moat and record trading volumes, which underpin disciplined capital allocation and strong cash returns to shareholders.

KKR Closes Major Deals and Books $2B Net Income Boost as Analysts Eye Significant Upside
- KKR completed the sale of USI Insurance Services to Aon plc, generating approximately $3.3 billion in after-tax proceeds and an expected $2.0 billion in Adjusted Net Income for Q4 2026.
- The firm finalized its $5.7 billion acquisition of Integer Holdings Corporation, a leading medical device contract development and manufacturing organization, signaling continued expansion into healthcare infrastructure.
- KKR joined Carlyle in providing approximately $475 million in new capital commitments to Litmus Music, supporting the growth of its music royalty platform and diversifying alternative asset exposure.

CME Group Highlights Dominance in Derivatives and Prediction Markets Amid Analyst Downside Warnings
- CEO Terry Duffy discussed the integration of prediction markets alongside traditional financial instruments during a recent appearance on 'Power Lunch', highlighting new revenue avenues.
- Analysts note that CME maintains a dominant position in global derivatives with exceptionally high net margins, supported by a technology partnership with Alphabet.
- The company is cited for its wide economic moat and record trading volumes, which underpin disciplined capital allocation and strong cash returns to shareholders.
Investment Analysis

KKR
KKR
Pros
- KKR reported strong Q3 2025 earnings, exceeding both EPS and revenue forecasts with robust growth in fee-related earnings.
- The firm achieved record fundraising and expanded its presence in high-growth areas such as private credit and Asian markets.
- KKR's acquisition of OSTTRA enhances its infrastructure and technology offerings, broadening its alternative asset management platform.
Considerations
- Despite strong results, KKR's stock has shown volatility and underperformed in pre-market trading, reflecting investor caution.
- The company trades at a high valuation multiple, which may limit upside and increase sensitivity to market sentiment.
- KKR's earnings are closely tied to fundraising cycles and capital markets activity, making them vulnerable to economic downturns.

CME Group
CME
Pros
- CME Group maintains a dominant position in global derivatives trading, benefiting from high trading volumes and market resilience.
- The company generates stable, recurring revenue from clearing and exchange fees, supporting strong cash flow generation.
- CME Group has a robust balance sheet and a history of returning capital to shareholders through dividends and buybacks.
Considerations
- CME Group's growth is limited by market saturation and regulatory scrutiny in the exchange sector.
- Revenue is sensitive to interest rate changes and macroeconomic conditions, which can impact trading activity.
- The company faces increasing competition from alternative trading platforms and fintech disruptors.
KKR (KKR) Next Earnings Date
KKR has not yet announced a confirmed date for its next earnings report. Based on the historical pattern of reporting approximately three months after the previous release, the upcoming announcement is expected in February 2027. This future report will cover the fourth quarter and full-year results for fiscal year 2026. Investors should monitor official company communications for the precise scheduling of this event.
CME Group (CME) Next Earnings Date
CME Group has not yet announced a confirmed date for its next earnings release. Based on the company's historical reporting pattern, which typically follows a three-month cycle after the previous quarter's close, the upcoming report is expected in February 2027. This scheduled update will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official corporate communications for the precise announcement timing.
KKR (KKR) Next Earnings Date
KKR has not yet announced a confirmed date for its next earnings report. Based on the historical pattern of reporting approximately three months after the previous release, the upcoming announcement is expected in February 2027. This future report will cover the fourth quarter and full-year results for fiscal year 2026. Investors should monitor official company communications for the precise scheduling of this event.
CME Group (CME) Next Earnings Date
CME Group has not yet announced a confirmed date for its next earnings release. Based on the company's historical reporting pattern, which typically follows a three-month cycle after the previous quarter's close, the upcoming report is expected in February 2027. This scheduled update will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official corporate communications for the precise announcement timing.
Buy KKR or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


